Roger Cox joined Plexus Ventures in 2009 following a 24 year career in business development within the healthcare industry, most recently with Johnson & Johnson.
Dr. Cox recently served as Executive Director, Licensing for Johnson & Johnson's Pharmaceuticals Group and was with J&J from 1992 until 2008. Roger has been lead negotiator on a variety of significant pharmaceutical transactions and, while with J&J, he negotiated over 50 commercial license agreements leading to 12 marketed products.
Besides his experience in 'Big Pharma', Dr. Cox has broad business development experience in the healthcare industry with smaller companies and also government organizations. Before joining J&J he was Group Licensing Manager for Medgenix Group SA based in Belgium and prior to that Commercial Director of IQ (Bio) Ltd, a Cambridge based immunodiagnostic company acquired by Novo in 1987. Between 1982-1984 he was a Senior Investment Executive with British Technology Group in London responsible for investments in unlisted biotechnology companies.
Dr. Cox holds a Bachelor's degree in Microbiology from the University of Bristol, a Ph.D. in microbial biochemistry from the University of Reading, conducted 2 years postdoctoral research at the University of Sheffield and attended the London Business School's Corporate Finance programme in 1982-1983.
Dr. Cox was Chairman of the European Pharmaceutical Licensing Council (2007-2009) and President/co-founder of the Pharmaceutical Licensing Group Benelux (1999-2010). He regularly presents a 2 day course on Pharmaceutical Licensing Negotiation.